Correlation Between Amylyx Pharmaceuticals and Zenas BioPharma,
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Zenas BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Zenas BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Zenas BioPharma, Common, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Zenas BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Zenas BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Zenas BioPharma,.
Diversification Opportunities for Amylyx Pharmaceuticals and Zenas BioPharma,
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Amylyx and Zenas is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Zenas BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zenas BioPharma, Common and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Zenas BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zenas BioPharma, Common has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Zenas BioPharma, go up and down completely randomly.
Pair Corralation between Amylyx Pharmaceuticals and Zenas BioPharma,
Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to under-perform the Zenas BioPharma,. But the etf apears to be less risky and, when comparing its historical volatility, Amylyx Pharmaceuticals is 1.46 times less risky than Zenas BioPharma,. The etf trades about -0.2 of its potential returns per unit of risk. The Zenas BioPharma, Common is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest 1,073 in Zenas BioPharma, Common on December 3, 2024 and sell it today you would lose (409.00) from holding Zenas BioPharma, Common or give up 38.12% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Amylyx Pharmaceuticals vs. Zenas BioPharma, Common
Performance |
Timeline |
Amylyx Pharmaceuticals |
Zenas BioPharma, Common |
Amylyx Pharmaceuticals and Zenas BioPharma, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Amylyx Pharmaceuticals and Zenas BioPharma,
The main advantage of trading using opposite Amylyx Pharmaceuticals and Zenas BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Zenas BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zenas BioPharma, will offset losses from the drop in Zenas BioPharma,'s long position.Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
Zenas BioPharma, vs. FT Vest Equity | Zenas BioPharma, vs. Zillow Group Class | Zenas BioPharma, vs. Northern Lights | Zenas BioPharma, vs. VanEck Vectors Moodys |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |